Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report.
Where this comes from
- Record sourced from PubMed, PMID 30825965.
- Also identified by DOI 10.1016/j.radonc.2018.11.005 and PMC identifier 7427834.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Survival in limited stage small cell lung cancer (LS-SCLC) improves with faster initiation of hyper-fractionated thoracic radiotherapy (TRT) following chemotherapy, however, it is unknown if this association exists for more commonly employed daily fractionated regimens. Our results suggest that this association is present even with daily fractionation.
Medical subject headings
- Lung Neoplasms
- Small Cell Lung Carcinoma